Clinical trial
Influence of Circulating Anti-beta2-glycoprotein I Antibodies on the Endothelial Function and NO Metabolism in Peripheral Arterial Disease Patients.
NCT01822990 is registered in ClinicalTrials.gov with Hospital Universitario Getafe as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Circulating Anti-beta2-glycoprotein I Antibodies on the Endothelial Function and NO Metabolism in Peripheral Arterial Disease Patients.
- Lead sponsor
- Hospital Universitario Getafe
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- July 31, 2012
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.